Sabre (NASDAQ: SABR) reported Q2 EPS of ($1.30), $0.46 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $83 million versus the consensus estimate of $162.78 million.

Business Outlook:

"Our thoughts continue to be with those around the world impacted by the COVID-19 pandemic," said Doug Barnett, CFO. "We continue to take the cost actions necessary in this difficult environment, including a recently signed contract extension with DXC that provides significant savings over its multi-year term. We remain committed to our expectation for approximately $275 million in 2020 cost savings and are working aggressively to position ourselves for growth post-COVID-19."

Given the magnitude and the uncertainty related to the COVID-19 pandemic and its economic effects, on March 20, 2020, Sabre withdrew its February 26, 2020 guidance and has not given further guidance at this time.

For earnings history and earnings-related data on Sabre (SABR) click here.